Duration of carriage of multidrug resistant Enterobacterales in discharged hospital and general practice patients and factors associated with clearance. Issue 3 (September 2020)

• Record Type: Journal Article
• Authors: van Weerlee, Celine; van der Vorm, Eric R.; Nolles, Loes; Meeuws-van den Ende, Saskia; van der Bij, Akke K.
• Is Part Of: Infection Prevention in Practice. Volume 2:Issue 3(2020)
• Publication Date: 2020-09
• Subjects: Multidrug resistant Enterobacterales -- Carriage -- Infection prevention; GP general practitioner -- HRMO highly resistant microorganisms -- EPD electronic patient record -- ESBL extended-spectrum beta-lactamase; Infection -- Prevention -- Periodicals; Infection Control; Infection -- Prevention; Electronic journals; Periodical; Electronic journals; Periodicals; 616.9045
• DOI: 10.1016/j.infpip.2020.100066
• Languages: English
• ISSNs: 2590-0889

Abstract

Summary: Objectives: Dutch guidelines recommend contact precautions in patients with multidrug resistant microorganisms cultured during the previous 12 months. To evaluate this policy, duration of carriage of multidrug resistant Enterobacterales was assessed among discharged hospital patients and patients attending their general practitioner (GP). Additionally, we assessed factors associated with clearance. Methods: From January 2013 until May 2016, rectal or faecal samples accompanied by questionnaires on patient characteristics were obtained at time of study inclusion and 3, 6 and 12 months later, in 72 patients with multidrug resistant Enterobacterales . Clearance was defined as one or more negative cultures without a subsequent positive culture at 12 months after study inclusion. The percentage of clearance, intermittent carriage and persistence was determined and associated factors were assessed by logistic regression analysis. Results: Clearance was found in 31 patients (43.1% [95%CI: 32.3–54.6]) of which 23 patients had two or more subsequent negative cultures. Twelve patients were classified as intermittent carriers (16.7% [95%CI: 9.8–26.9]) and 29 patients (40.3% [95% CI: 29.7–51.8]) as persistent carriers. Of the intermittent carriers, the majority (n=9) had two negative cultures during the study period. There was no difference in clearance between discharged hospitalized patients and GP patients. The only factor associated with clearance at 12 months in both univariable and multivariable analyses was not traveling to a foreign country (OR=3.5 [95%CI: 1.0–12.4]). Conclusion: Active screening for clearance of multidrug resistant Enterobacterales in patients within the health care setting is probably not beneficial due to high levels of intermittent and persistent carriage.